U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07761806) titled 'Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile Dysfunction' on Aug. 08.
Brief Summary: Erectile dysfunction (ED) is defined as the inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance.Erectile dysfunction (ED) is one of the commonest disorders in adult males and affects 12-19% of men of reproductive age.Erectile dysfunction can be due to vasculogenic, neurogenic, hormonal, veno-occlusive, psychogenic and/or pharmacogenic factors.
PRP is autologous plasma that has a platelet concentration above the concentrations typically found in whole blood and is derived from the...